List of Excipients in API BUPIVACAINE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BUPIVACAINE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Renaissance Lakewood LLC | POSIMIR | bupivacaine | 49396-6601 | BENZYL ALCOHOL | |
| Renaissance Lakewood LLC | POSIMIR | bupivacaine | 49396-6601 | SUCROSE ACETATE ISOBUTYRATE | |
| INNOCOLL PHARMACEUTICALS | POSIMIR | bupivacaine | 51715-660 | BENZYL ALCOHOL | |
| INNOCOLL PHARMACEUTICALS | POSIMIR | bupivacaine | 51715-660 | SUCROSE ACETATE ISOBUTYRATE | |
| Heron Therapeutics Inc | ZYNRELEF | bupivacaine and meloxicam | 47426-301 | DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER | 2035-04-20 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BUPIVACAINE
Detailed excipient profiles for BUPIVACAINE
Excipient focus: ANHYDROUS DEXTROSE
BUPIVACAINE drug variants containing ANHYDROUS DEXTROSE
BUPIVACAINE drug variants not containing ANHYDROUS DEXTROSE
Excipient focus: ASCORBIC ACID
BUPIVACAINE drug variants containing ASCORBIC ACID
BUPIVACAINE drug variants not containing ASCORBIC ACID
Excipient focus: BENZYL ALCOHOL
BUPIVACAINE drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing BENZYL ALCOHOL
Excipient focus: CITRIC ACID MONOHYDRATE
BUPIVACAINE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
| REMEDYREPACK INC | bupivacaine hydrochloride and epinephrine bitartrate | 70518-2657 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER
BUPIVACAINE drug variants containing DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER
Excipient focus: DEXTROSE
BUPIVACAINE drug variants containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Brookfield Pharmaceuticals LLC | bupivacaine hydrochloride | 71351-022 |
| Huons Co Ltd | bupivacaine hydrochloride | 73293-0002 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing DEXTROSE
Excipient focus: DIMETHYL SULFOXIDE
BUPIVACAINE drug variants containing DIMETHYL SULFOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing DIMETHYL SULFOXIDE
Excipient focus: EDETATE CALCIUM DISODIUM
BUPIVACAINE drug variants containing EDETATE CALCIUM DISODIUM
BUPIVACAINE drug variants not containing EDETATE CALCIUM DISODIUM
Excipient focus: HYDROCHLORIC ACID
BUPIVACAINE drug variants containing HYDROCHLORIC ACID
BUPIVACAINE drug variants not containing HYDROCHLORIC ACID
Excipient focus: MALEIC ACID
BUPIVACAINE drug variants containing MALEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing MALEIC ACID
Excipient focus: METHYLPARABEN
BUPIVACAINE drug variants containing METHYLPARABEN
BUPIVACAINE drug variants not containing METHYLPARABEN
Excipient focus: MONOTHIOGLYCEROL
BUPIVACAINE drug variants containing MONOTHIOGLYCEROL
BUPIVACAINE drug variants not containing MONOTHIOGLYCEROL
Excipient focus: NITROGEN
BUPIVACAINE drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Brookfield Pharmaceuticals LLC | bupivacaine hydrochloride | 71351-022 |
| Huons Co Ltd | bupivacaine hydrochloride | 73293-0002 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing NITROGEN
Excipient focus: SODIUM CHLORIDE
BUPIVACAINE drug variants containing SODIUM CHLORIDE
BUPIVACAINE drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
BUPIVACAINE drug variants containing SODIUM HYDROXIDE
BUPIVACAINE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LACTATE
BUPIVACAINE drug variants containing SODIUM LACTATE
BUPIVACAINE drug variants not containing SODIUM LACTATE
Excipient focus: SODIUM METABISULFITE
BUPIVACAINE drug variants containing SODIUM METABISULFITE
BUPIVACAINE drug variants not containing SODIUM METABISULFITE
Excipient focus: SUCROSE ACETATE ISOBUTYRATE
BUPIVACAINE drug variants containing SUCROSE ACETATE ISOBUTYRATE
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing SUCROSE ACETATE ISOBUTYRATE
Excipient focus: TRIACETIN
BUPIVACAINE drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing TRIACETIN
Excipient focus: WATER
BUPIVACAINE drug variants containing WATER
BUPIVACAINE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
